Seegene is a leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics. The company’s technologies enable MDx tests that can simultaneously detect multiple targets with high sensitivity, specificity and reproducibility. Seegene offers M-MDx tests in infectious diseases, genetics, pharmacogenetics, and oncology, and actively partners in the development of new tests utilizing its breakthrough multiplex molecular technologies.
Included in the Export Interest Directory? No